Yihan Li Selected Research

Rheumatoid Arthritis

8/2023	Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.
1/2022	Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension study.
1/2022	Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study.
1/2022	Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program.
1/2021	Switching between Janus kinase inhibitor upadacitinib and adalimumab following insufficient response: efficacy and safety in patients with rheumatoid arthritis.
11/2019	Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials.
11/2019	Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial.
11/2019	Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.
1/2019	Effects of Huatan Tongluo decoction on vascular endothelial growth factor receptor 2 expression in synovial tissues of rats with collagen-induced arthritis.
11/2018	Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yihan Li Research Topics

Disease

15	Rheumatoid Arthritis 08/2023 - 07/2016
12	Infections 10/2023 - 01/2013
11	Neoplasms (Cancer) 05/2024 - 01/2013
5	Pain (Aches) 05/2024 - 11/2019
4	Herpes Zoster 01/2022 - 01/2018
3	Psoriatic Arthritis 11/2023 - 11/2018
2	Non-Radiographic Axial Spondyloarthritis 05/2024 - 01/2022
2	Opportunistic Infections (Opportunistic Infection) 05/2024 - 01/2022
2	Inflammation (Inflammations) 05/2024 - 01/2022
2	Headache (Headaches) 01/2024 - 01/2018
2	Cognitive Dysfunction 01/2023 - 12/2021
2	Ankylosing Spondylitis 01/2023 - 01/2022
2	Rolandic Epilepsy (Centrotemporal Epilepsy) 01/2023 - 10/2021
2	Atrial Fibrillation 01/2023 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 07/2022
2	Osteoarthritis 12/2020 - 01/2020
2	Hypersensitivity (Allergy) 11/2018 - 11/2018
2	Major Depressive Disorder (Major Depressive Disorders) 12/2015 - 02/2012
2	Breast Neoplasms (Breast Cancer) 04/2014 - 04/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2024
1	Esophageal Neoplasms (Esophageal Cancer) 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Sarcopenia 02/2024
1	Migraine Disorders (Migraine) 01/2024
1	Frailty 01/2024
1	Nasopharyngeal Carcinoma 12/2023
1	Musculoskeletal Pain 10/2023
1	Apnea 01/2023
1	Obstructive Sleep Apnea 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Back Pain (Backache) 01/2023
1	Tic Disorders (Tic Disorder) 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2023
1	Bradycardia 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Motor Skills Disorders (Motor Skills Disorder) 01/2023
1	Neurodevelopmental Disorders 01/2023
1	Tourette Syndrome (Tourette's Syndrome) 01/2023
1	Shock 11/2022
1	Bone Resorption 10/2022
1	Atrophy 07/2022
1	Colorectal Neoplasms (Colorectal Cancer) 02/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022

Drug/Important Bio-Agent (IBA)

12	upadacitinibIBA 05/2024 - 01/2018
8	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2022
5	Janus Kinase InhibitorsIBA 08/2023 - 01/2021
5	Adalimumab (Humira)FDA Link 01/2022 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 08/2012
3	Antirheumatic Agents (DMARD)IBA 11/2023 - 01/2018
3	CollagenIBA 10/2022 - 04/2014
3	C-Reactive ProteinIBA 01/2022 - 01/2018
3	Interleukin-17 (Interleukin 17)IBA 11/2018 - 11/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 01/2014
2	AntigensIBA 10/2021 - 01/2013
2	Anticonvulsants (Antiepileptic Drugs)IBA 10/2021 - 01/2021
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2020 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2013
2	Therapeutic UsesIBA 01/2019 - 07/2016
2	huatan tongluoIBA 01/2019 - 07/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 11/2018
2	ABT-122IBA 11/2018 - 11/2018
1	Caspase 1 (ICE Protease)IBA 04/2024
1	androsterone sulfateIBA 02/2024
1	CreatineIBA 02/2024
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2024
1	Pyruvic Acid (Pyruvate)IBA 02/2024
1	Monoclonal AntibodiesIBA 02/2024
1	Vitamin D FDA LinkGeneric 01/2024
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2024
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2024
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2024
1	Vitamin E FDA LinkGeneric 01/2024
1	MicronutrientsIBA 01/2024
1	Vitamin B 6IBA 01/2024
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2023
1	Hematoxylin (Haematoxylon)IBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2023
1	SiliconIBA 10/2023
1	Hormones (Hormone)IBA 10/2023
1	dicarboxydine (DCD)IBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Dronedarone FDA Link 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2023
1	NitrogenIBA 11/2022
1	NitritesIBA 11/2022
1	WastewaterIBA 11/2022
1	Matrix Metalloproteinases (MMPs)IBA 10/2022
1	IntegrinsIBA 07/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 07/2022
1	CalnexinIBA 02/2022

Therapy/Procedure

6	Therapeutics 05/2024 - 11/2019
2	Immunotherapy 02/2024 - 12/2021
1	Traditional Medicine (Folk Remedies) 04/2024
1	Biological Therapy 01/2023
1	Patient Readmission 01/2023
1	Catheter Ablation 01/2023